J 2021

The Role of ATRA, Natural Ligand of Retinoic Acid Receptors, on EMT-Related Proteins in Breast Cancer: Minireview

BOBÁĽ, Pavel, M. LASTOVICKOVA and J. BOBALOVA

Basic information

Original name

The Role of ATRA, Natural Ligand of Retinoic Acid Receptors, on EMT-Related Proteins in Breast Cancer: Minireview

Authors

BOBÁĽ, Pavel (703 Slovakia, belonging to the institution), M. LASTOVICKOVA and J. BOBALOVA (guarantor)

Edition

International Journal of Molecular Sciences, Basel, Multidisciplinary Digital Publishing Institute, 2021, 1422-0067

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 6.208

RIV identification code

RIV/00216224:14160/21:00124008

Organization unit

Faculty of Pharmacy

UT WoS

000738236600001

Keywords in English

breast cancer; EMT; protein; ATRA

Tags

Tags

International impact, Reviewed
Změněno: 31/1/2022 15:47, JUDr. Sabina Krejčiříková

Abstract

V originále

The knowledge of the structure, function, and abundance of specific proteins related to the EMT process is essential for developing effective diagnostic approaches to cancer with the perspective of diagnosis and therapy of malignancies. The success of all-trans retinoic acid (ATRA) differentiation therapy in acute promyelocytic leukemia has stimulated studies in the treatment of other tumors with ATRA. This review will discuss the impact of ATRA use, emphasizing epithelial-mesenchymal transition (EMT) proteins in breast cancer, of which metastasis and recurrence are major causes of death.

Links

MUNI/A/1682/2020, interní kód MU
Name: Návrh, syntéza a hodnocení derivátů skupin léčiv s inhibiční enzymatickou aktivitou
Investor: Masaryk University